Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSome people taking Wegovy notice their hands feel unusually cold, particularly in the first weeks of treatment. This is a real, reported experience — and there are a few plausible explanations grounded in how semaglutide works. It is not listed as a common side effect in the Wegovy SmPC, but it is not unheard of either. As with any symptom that concerns you, a GPhC-registered prescriber should be your first call, because Wegovy is a prescription-only medicine that requires ongoing clinical oversight to use safely.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The NHS medicines page for semaglutide lists the known common side effects of Wegovy as predominantly gastrointestinal: nausea, vomiting, diarrhoea, constipation, indigestion and fatigue. Cold hands are not among them. That matters, because it means the symptom is not a direct pharmacological effect that was consistently observed across the STEP clinical programme.
The STEP 1 trial, published in the New England Journal of Medicine, followed 1,961 adults on semaglutide 2.4mg for 68 weeks and produced an average body-weight reduction of around 15%. Participant-level data from that scale of trial would almost certainly have flagged peripheral coldness as a common effect if it emerged reliably. It did not, which suggests what people experience is more likely secondary: a consequence of the metabolic and physiological changes that rapid weight loss brings, rather than a direct action of the drug on blood vessels.
That distinction is worth holding onto. It does not mean your cold hands are imaginary. It means the mechanism is probably indirect, and understanding it helps you manage it more confidently. Worth checking: press a fingernail firmly for a second and release, healthy capillary refill returns pink colour within about two seconds. Slower than that, or fingers that turn white or blue, is a reason to contact your prescriber promptly.
When calorie intake drops sharply (and Wegovy reduces appetite considerably) the body adjusts its energy priorities. One of the quieter adaptations is a modest reduction in basal metabolic rate and a redistribution of blood flow away from the extremities toward the organs that need it most. Hands and feet, being furthest from the heart, feel this first.
Semaglutide also slows gastric emptying. That mechanism underpins much of its effect on appetite and blood-sugar control, but it can also reduce the post-meal warmth that comes from digestion. Meals generate heat; smaller, slower meals generate less. People on Wegovy often report eating far less than they used to, sometimes skipping meals altogether. Over weeks, that reduced thermogenic load can translate into feeling persistently colder.
There is also the question of fluid intake. Nausea (one of the most common early side effects) can put people off drinking enough water. Mild dehydration reduces plasma volume, which in turn reduces peripheral circulation. Feeling cold generally on Wegovy is a related experience that shares some of these same roots.
For most people, cool hands during Wegovy treatment settle as the body adapts to a lower calorie intake and the dose stabilises. Keeping warm, eating protein-adequate meals (even small ones), and staying hydrated are practical first steps. If you notice the coldness is confined strictly to the hands and feet, comes on after dose increases, and eases between doses, that pattern is consistent with the physiological explanation above, and our dedicated page on Wegovy and cold hands explores that pattern in more detail.
There are situations that need professional review rather than watchful waiting. If the skin on your hands changes colour (turning white, then blue, then red in the cold) that may point to Raynaud's phenomenon, a circulatory condition that is not caused by Wegovy but that the changes in your body during treatment could make more noticeable. Numbness, tingling, or coldness that is asymmetric (one hand much worse than the other) also warrants a call. So does any symptom that is worsening rather than stable. Cold hands and feet on semaglutide covers the feet-specific side of this picture too, if that is also something you are noticing.
You can report any suspected side effect of a prescription medicine through the MHRA's Yellow Card scheme, it is open to patients as well as clinicians, and your report genuinely contributes to the ongoing safety monitoring of medicines like Wegovy.
Practical day-to-day steps are straightforward. Prioritise warmth at the start and end of the day. Eat regularly enough to keep digestion ticking over, even if portions are small, skipping breakfast entirely to manage nausea tends to make peripheral coldness worse by mid-morning. Layer up in cold weather rather than relying on the body heat you had before treatment. Light movement, even a short walk, raises peripheral temperature quickly.
On the clinical side, if cold hands are noticeably affecting your quality of life, that conversation belongs at your next prescriber review. Some people also find they feel generally chilly throughout the day, and if that sounds familiar, our page on whether Wegovy makes you feel cold looks at why that broader sensation occurs. A prescriber may consider whether your current dose is the right one given how you are tolerating it, or whether there is an underlying circulatory factor worth investigating. You can find out more about the treatment broadly at our Wegovy information page, and a full overview of our weight-loss programme is on the weight-loss treatments page.
If you are yet to start Wegovy and are researching what to expect, our clinical team at nume reviews every consultation personally, a real prescriber, not an automated system, assesses whether treatment is clinically suitable for you before anything is dispensed. Patients sometimes ask about feeling cold on semaglutide before they begin, and it is exactly the kind of question worth raising at that stage. Start your free consultation if you would like that process to begin.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.